Janus Kinase Inhibitor
10 drugs across 4 manufacturers|0 Generic,10 Brand
Total Drugs
10
0G / 10B
Manufacturers
4
Avg $181.1459/unit
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
10 flat
of 10 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
4 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
RINVOQ ER 45 MG TABLET Upadacitinib | $460.0432 per EA | — |
RINVOQ ER 15 MG TABLET Upadacitinib | $229.2074 per EA | — |
RINVOQ ER 30 MG TABLET Upadacitinib | $228.8254 per EA | — |
XELJANZ XR 11 MG TABLET tofacitinib | $207.7104 per EA | — |
CIBINQO 100 MG TABLET abrocitinib | $197.1952 per EA | — |
OLUMIANT 4 MG TABLET baricitinib | $184.6623 per EA | — |
XELJANZ 10 MG TABLET tofacitinib | $103.5456 per EA | — |
OLUMIANT 2 MG TABLET baricitinib | $92.2936 per EA | — |
XELJANZ 5 MG TABLET tofacitinib | $73.8329 per EA | — |
OPZELURA 1.5% CREAM ruxolitinib | $34.1433 per GM | — |